Chronic Graft Versus-Host Disease Medications

Imbruvica is part of the Kinase Inhibitors class and treats Chronic Graft Versus-Host Disease and Non-Hodgkin Lymphoma. Kinase inhibitors are used to treat cancers such as leukemia, breast cancer, melanoma, lung cancer, and renal cancer. They are also used to prevent organ transplant rejection. They work by stopping cancer cell growth and preventing the spread of the cells. Imbruvica is only available as a brand name drug.

Niktimvo is part of the Anti-CSF-1R Antibodies class and treats Chronic Graft Versus-Host Disease. Anti-CSF-1R antibodies, also known as anti-colony stimulating factor 1 receptor antibodies, are used to treat chronic graft versus host disease. They work by reducing the level of inflammatory cells in the body. Niktimvo is only available as a brand name drug.

BELUMOSUDIL treats graft versus host disease, a condition that can occur after a stem cell transplant. It is prescribed when other medications have not worked well enough. It works by decreasing inflammation. It also prevents the buildup of scar tissue.